Marshall Wace, LLP Sab Biotherapeutics Inc Wt Exp Transaction History
Marshall Wace, LLP
- $90.8 Billion
- Q3 2025
A detailed history of Marshall Wace, LLP transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Marshall Wace, LLP holds 247,576 shares of SABSW stock, worth $7,427. This represents 0.0% of its overall portfolio holdings.
Number of Shares
247,576Holding current value
$7,427% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SABSW
# of Institutions
13Shares Held
908KCall Options Held
62.5KPut Options Held
0-
Lmr Partners LLP London, X0540KShares$16,1870.0% of portfolio
-
Morgan Stanley New York, NY146KShares$4,3930.0% of portfolio
-
Clear Street Group Inc. New York, NY79KShares$2,3700.0% of portfolio
-
Clear Street LLC78.8KShares$2,3640.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA26.3KShares$7890.0% of portfolio
About SAB BIOTHERAPEUTICS INC WT EXP
- Ticker SABSW
- Sector Healthcare
- Industry Biotechnology